Forum Replies Created
Viewing 0 reply threads
- Replies
-
-
- August 7, 2019 at 7:09 am
The U.S. Food and Drug Administration (FDA) approved the first-ever therapy for the treatment of a rare disease called tenosynovial giant cell tumors (TGCT). -
- June 6, 2019 at 9:44 am
Keytruda and Opdivo both are proven immunotherapy drug, as both are potent and proven drug they often recommended for each other alternative. 23% of patients who received Keytruda drug survived at least five years more, in the past only was 5% patient survived.
Source – https://www.myhealthyclick.com/newer-drugs-improve-survival-chances-for-people-with-lung-breast-prostate-cancers/
-
Viewing 0 reply threads